Myrtle S. Potter - Jun 13, 2024 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role
Director
Signature
/s/ Karen Tepichin, Attorney-in-Fact
Stock symbol
DNA
Transactions as of
Jun 13, 2024
Transactions value $
$0
Form type
4
Date filed
6/14/2024, 04:18 PM
Previous filing
Jun 13, 2024
Next filing
Jun 17, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNA Stock Option Award $0 +1.11M $0.00 1.11M Jun 13, 2024 Class A Common Stock 1.11M $0.46 Direct F1, F2
transaction DNA Stock Option Award $0 +571K $0.00 571K Jun 13, 2024 Class A Common Stock 571K $0.46 Direct F3, F4
transaction DNA Restricted Stock Units Award $0 +433K $0.00 433K Jun 13, 2024 Class A Common Stock 433K $0.00 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In accordance with the Non-Employee Director Compensation Program of the Issuer, the Black-Scholes value of the initial option award as of the grant date is $400,000.
F2 The initial stock options shall vest and become exercisable in substantially equal installments on each of the first three anniversaries of the date of grant, such that the initial stock options shall be fully vested on the third anniversary of the date of grant, subject to the Reporting Person continuing in service as a Non-Employee Director through such date.
F3 In accordance with the Non-Employee Director Compensation Program of the Issuer, the Black-Scholes value of the additional initial option award as of the grant date is $200,000.
F4 The vesting date of the RSUs and additional initial options, and in the case of the additional initial options, the exercise date, will be the day immediately prior to the date of the next Annual Meeting of Shareholders of the Issuer occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such date.
F5 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.